Effect of Listening to Standardized Music Sequences on Preventing Postoperative Pain in Proctologic Surgery (MUSICOPROCTO)

June 25, 2025 updated by: Clinique Saint-Vincent

The study, "Effect of Listening to Standardized Music Sequences on Preventing Postoperative Pain in Proctologic Surgery," aims to evaluate the impact of preoperative listening to standardized music sequences on postoperative pain in patients undergoing proctologic surgery (for hemorrhoids, fistulas, or anal fissures).

This research will assess the influence of preoperative music on postoperative pain management, the use of analgesics after surgery and during the following month, and its effect on the quality of life post-surgery.

MUSICO-PROCTO is an interventional, randomized study involving two groups (patients will be randomly assigned to either the music intervention or control group). The study is monocentric, conducted at Clinique Saint Vincent in France, and includes 550 participants.

Participants will be followed for 28 days, while the overall study duration will span 28 months.

To participate, individuals must:

Be aged 18 or older. Be affiliated with a social security system. Provide signed informed consent. Undergo proctologic surgery for hemorrhoids, fistulas, or anal fissures. This study seeks to explore the potential of music as a complementary method to improve postoperative outcomes.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

550

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Saint Denis, Réunion, 97404
        • Not yet recruiting
        • Clinique Saint Vincent
        • Contact:
        • Principal Investigator:
          • Sarah BEKKAR, Doctor
        • Sub-Investigator:
          • Guylène Gadsaud Dauvin, Doctor
      • Saint Denis, Réunion, 97404

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male or female, aged over 18 years.
  • Patient who has signed an informed consent form.
  • Patient scheduled to undergo proctological surgery (for hemorrhoids, fistula, or anal fissure) at the participating institution.
  • Must be affiliated with a social security system or be a beneficiary of such a system.
  • Patient must have access to the necessary technical means (smartphone, computer, tablet) to use the Music Care® application.

Exclusion Criteria:

  • Refusal to consent.
  • Patient unable to read, write, or understand French.
  • Vulnerable patient according to Article L1121-6 of the French Public Health Code (CSP).
  • Adult patient under guardianship or curatorship or under legal protection (safeguard of justice).
  • Patient unable to personally give informed consent according to Article L.1121-8 of the CSP or an adult protected by law.
  • Pregnant or breastfeeding women according to Article L1121-5 of the CSP.
  • Patient who has already participated in a study within the last 12 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standardized Music Listening

Participants assigned to this arm will benefit from standardized music listening sessions via the Music Care® application.

Pre-surgery: At the entrance to the operating room, participants will spend 20 minutes lying on a stretcher in a dedicated room, listening to relaxing music sequences through a tablet and headphones provided by the research team. Participants can select their preferred musical style, tempo, and tracks.

Post-surgery: Participants will continue listening to music sequences daily for 20 minutes at home using their own devices (smartphone, tablet, or computer) until day 28 post-surgery.

Type of Intervention: Pre- and postoperative listening to standardized music sequences designed specifically for relaxation and pain management.

Delivery Method: Sessions are conducted via the Music Care® application, using a tablet and headphones provided during hospitalization. Participants select their preferred music style, tempo, and tracks to tailor the experience to their preferences.

Duration and Schedule:

Pre-surgery: One 20-minute session in a dedicated room before entering the operating theater.

Post-surgery: Daily 20-minute sessions at home for 28 days post-surgery using participants' own devices (smartphone, tablet, or computer).

Purpose: To evaluate the effect of music on reducing postoperative pain, minimizing analgesic use, and improving the quality of life.

Distinctiveness: This intervention uniquely integrates patient-controlled music preferences with a structured listening regimen before and after surgery, offering a personalized approach to enhancing recovery outcom

No Intervention: Standard Care

Participants assigned to this arm will not benefit from standardized music listening sessions.

Pre-surgery: Participants will proceed directly from their hospital room to the operating room without a music listening session.

Post-surgery: Participants will be managed according to standard care practices, with no additional interventions related to music therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity (EVA Pain) in the recovery room (SSPI).
Time Frame: Immediately post-surgery in the recovery room.
First postoperative pain measurement using the EVA (Visual Analog Scale), scored from 0 to 10, in the recovery room (SSPI).
Immediately post-surgery in the recovery room.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Analgesic Consumption During Hospital Stay
Time Frame: Measured from hospital admission to hospital discharge, within an estimated time frame of 6 to 24 hours (due to the outpatient nature of the procedure).
The total amount of analgesic medication consumed during the entire hospital stay.
Measured from hospital admission to hospital discharge, within an estimated time frame of 6 to 24 hours (due to the outpatient nature of the procedure).
Successive Pain and Anxiety Scores (EVA Pain and EVA Anxiety)
Time Frame: From hospitalization to Day 28 post-surgery.

Successive measurements of pain and anxiety using the EVA scales, scored from 0 to 10, at the following time points:

Admission to hospitalization. 30 minutes after premedication. In the recovery room (SSPI). At hospital discharge. Day 10 (±3 days). Day 28 (follow-up visit).

From hospitalization to Day 28 post-surgery.
State Anxiety Score (STAI-Y-ETAT)
Time Frame: From hospitalization to Day 28 post-surgery.

Evaluation of state anxiety using the STAI-Y-ETAT scale at the following time points:

Admission to hospitalization. 30 minutes after premedication. At hospital discharge. Day 28 (follow-up visit)

From hospitalization to Day 28 post-surgery.
Kess Score
Time Frame: From hospitalization to Day 28 post-surgery

Measurement of bowel function using the Kess score at the following time points:

Admission to hospitalization. 30 minutes after premedication. Day 10 (±3 days). Day 28 (follow-up visit).

From hospitalization to Day 28 post-surgery
Total Time in SSPI and Hospitalization Duration
Time Frame: During the hospital stay.
Measurement of the total time spent in the recovery room (SSPI) and overall hospitalization duration.
During the hospital stay.
Time to Healing
Time Frame: From surgery to Day 28 post-surgery.
Measurement of wound healing time by assessing wound surface area using the Imito Measure application, in the genu-pectoral position.
From surgery to Day 28 post-surgery.
Quality of Life Scores (HEMO-FISS-QoL and EQ5D-5L)
Time Frame: From hospitalization to Day 28 post-surgery.

Assessment of quality of life using the HEMO-FISS-QoL and EQ5D-5L scales at the following time points:Admission to hospitalization.

Day 28 (follow-up visit).

From hospitalization to Day 28 post-surgery.
Patient Satisfaction
Time Frame: Immediately post-surgery, upon discharge from SSPI.
Measurement of patient satisfaction using a Likert scale upon discharge from the recovery room (SSPI).
Immediately post-surgery, upon discharge from SSPI.
Medico-Economic Impact
Time Frame: During the hospital stay.

Assessment of the economic impact of the intervention by recording:

Operative times. Recovery room durations. Total hospitalization duration (in minutes).

During the hospital stay.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

January 17, 2025

First Submitted That Met QC Criteria

January 22, 2025

First Posted (Actual)

January 29, 2025

Study Record Updates

Last Update Posted (Actual)

June 26, 2025

Last Update Submitted That Met QC Criteria

June 25, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anal Fistulas

Clinical Trials on Standardized Music Listening Therapy

Subscribe